Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Clinical trial NCT05936229 · WITHDRAWN

Trial details

NCT number: NCT05936229
Sponsor: Fred Hutchinson Cancer Center
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent B Acute Lymphoblastic Leukemia Recurrent B-Cell Non-Hodgkin Lymphoma Refractory B Acute Lymphoblastic Leukemia Refractory B-Cell Non-Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma

Start date: 2025-04-01
Primary completion: 2027-10-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.